According to the WSJ and other source, the FDA has rejected Genetech’s (DNA) drug Avastin as a breast cancer treatment. Shares are off 9% on the news
Douglas A. McIntyre
FDA Rejects Genetech (DNA) Cancer Drug, Shares Off 9%
According to the WSJ and other source, the FDA has rejected Genetech’s (DNA) drug Avastin as a breast cancer treatment. Shares are off 9% on the news
Douglas A. McIntyre
